The jury is still out on oestrogens and oestrogen/progestin and the heart [2] (multiple letters)

dc.contributor.authorCheifitz R.L.
dc.contributor.authorHough S.
dc.date.accessioned2011-05-15T15:56:43Z
dc.date.available2011-05-15T15:56:43Z
dc.date.issued2003
dc.description.abstract[No abstract available]
dc.description.versionLetter
dc.identifier.citationCardiovascular Journal of South Africa
dc.identifier.citation14
dc.identifier.citation1
dc.identifier.issn10159657
dc.identifier.urihttp://hdl.handle.net/10019.1/10002
dc.subjectestrogen
dc.subjectgestagen
dc.subjectraloxifene
dc.subjectbreast cancer
dc.subjectcardiovascular disease
dc.subjectcardiovascular risk
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectdose response
dc.subjectdrug indication
dc.subjectestrogen therapy
dc.subjectheart protection
dc.subjecthigh risk population
dc.subjecthormone substitution
dc.subjecthuman
dc.subjectischemic heart disease
dc.subjectletter
dc.subjectpatient selection
dc.subjectprimary prevention
dc.subjectrandomized controlled trial
dc.subjectrisk assessment
dc.subjectstroke
dc.subjectthromboembolism
dc.subjecttreatment indication
dc.subjecttreatment outcome
dc.subjectCoronary Disease
dc.subjectEstrogen Replacement Therapy
dc.subjectEstrogens
dc.subjectFemale
dc.subjectHumans
dc.subjectProgestins
dc.subjectRisk Factors
dc.subjectTreatment Failure
dc.titleThe jury is still out on oestrogens and oestrogen/progestin and the heart [2] (multiple letters)
dc.typeLetter
Files